GC Biopharma wins contract to build blood products plant in Indonesia

The company has received approval from the Indonesian gov't for the construction and technology transfer of blood products plant

GC Biopharma's headquarters
GC Biopharma's headquarters
Ji-Hyun Lee 1
2023-06-02 09:45:36 bluesky@hankyung.com
Bio & Pharma

GC Biopharma Corp., a South Korean pharmaceutical company, announced on Thursday that it has received approval from the Indonesian Ministry of Health for the construction and technology transfer of a blood products plant.

The Indonesian government has been undertaking the selection process for business rights in order to produce blood products domestically, reducing dependency on imports.

GC Biopharma was selected as the preferred negotiator in January and has since gone through detailed discussions and coordination before officially winning the approval. The specific contract size and details will be disclosed after the contract is finalized.

"This achievement is significant as it reflects the collaboration between our government and private enterprises, resulting in the successful bid for the business rights from a foreign government in the biopharmaceutical industry," said a company official.

GC Biopharma has been producing various blood products since the 1970s, starting with albumin. It has exported blood product plants to Thailand and has experience building factories in countries such as China and Canada.

Write to Ji-Hyun Lee at bluesky@hankyung.com
#GC Biopharma #Indonesian Ministry of Health #blood products plant #albumin #technology transfer #preferred negotiator #korea gc biopharma

GC Biopharma wins $44 mn flu vaccine order from WHO agency

GC Biopharma wins $44 mn flu vaccine order from WHO agency

South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a drug tender offered by the Pan American Health Organization (PAHO), an arm of the World Health Organization (WHO).Accordingly, GC's flu vaccine wil

GC Biopharma's licensed flu vaccine gets approval in Taiwan

GC Biopharma's licensed flu vaccine gets approval in Taiwan

South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the Taiwanese Food and Drug Administration within the Ministry of Health and Welfare.The company licensed the vaccine to Medigen Vaccine Biologics Cor

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

GC Biopharma to develop mRNA flu vaccine with Canadian pharma

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The drug maker said it has exercised an option contract with Acuitas Therapeutics, a Canadian pharma that specializes in lipid nano particle (LNP) deliv

GC Biopharma introduces candidates for treating blood coagulation disease

GC Biopharma introduces candidates for treating blood coagulation disease

Nassim Usman, CEO of Catalyst Biosciences(left) and Huh Eun-chul, CEO of GC Biopharma South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based drug development firm, in order to introduce drug candidates

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine

South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter the World Health Organization (WHO) procurement market with Barycela following its export hit Suduvax. This breakthrough is expected to heat up glob
(* comment hide *}